CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>60%

NCT02435732 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Kidney Failure

Interventions

DRUG: Placebo saline solution
DRUG: Heparin
DRUG: CINRYZE

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]